198HO00195 COVERTRY

Print/PDF
Registration Name VANHOLLAND COVERTRY TV TL TY
Registration Number HONLD000760667510
Primary NAAB Code 198HO00195
Secondary Code(s)
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 9/25/2012
aAa 432516
DMS -
GFI 8.4%
Genetic Codes * TL TV TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5C, HH6T, HCD-T, HMWT
Sire COOKIECUTTER MOM HUNTER-ET
MGS RI-VAL-RE 2338 NIAGRA-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin BB
INDEXES
NM$ -230, 83% R CM$ -251
NM Percentile 12% FM$ -180
GTPI 2167 GM$ -264
PRODUCTION TRAITS
511 Dtrs 214 herds 0 % US 90% R
Milk 503 Fat, % -11 , -0.12%
SCS 2.89, 89% R Protein, % -1 , -0.07%
Feed Saved -131 , 55% R Milking Speed 7.14 , 62% R
Health & Fertility
Productive Life -1.7      87% R Mastitis -2.1      75% R
Heifer Livability 0.1       56% R Metritis -1.4      71% R
Livability -1.7      82% R D. Abom -0.7      74% R
DPR -1.7      88% R Ketosis -1.1      71% R
FSC -6.2      78% R R. Placenta -0.8      72% R
HCR -1.2      81% R Milk Fever -0.1      64% R
CCR -2.4      87% R
SCR -        -
DIA -0.2      43% R
RSP 1.2      49% R
Calving Traits
Sire CE 1.6      49% R 567 Obs
Daughter CE 2.2      36% R 0 Obs, 405 Dtrs
Sire SB 4.3      40% R 1002 Obs
Daughter SB 5.7      45% R 0 Obs, Dtrs
Gestation Length 0.7      77% R 0 Obs, 0 Dtrs
Early First Calving 1.6      77% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
376 Dtrs 167 herds 88% R
PTA Type -0.61 UDC -1.15
HCC 0.01 BWC 0.31
FLC -1.10
Linear Traits
Stature -0.27
Short
Strength 0.30
Weak
Body Depth 0.29
Deep
Dairy Form -0.26
Closed
Rump Angle 0.52
Sloped
Thurl Width 0.04
Sloped
Rear Legs-Side View 0.04
Wide
Rear Legs-Rear View -1.30
H.-in
Foot Angle -0.44
Low
Feet & Legs Score -1.05
Low
F.U. Attachment 0.28
Curved
Rear Udder Height -1.36
Low
Rear Udder Width -1.17
Narrow
Udder Cleft -0.16
Weak
Udder Depth -1.30
H.-in
Front Teat Placement -0.37
Wide
Rear Teat Placement -0.16
Wide
Teat Length 1.42
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO